Sales & Marketing Views & Analysis

Views & Analysis

Sales & Marketing

The B2C prescription: Marketing lessons for B2B pharma compa...

B2B is often seen to lag behind B2C in marketing, and nowhere is that more true than in the pharmaceuticals industry.

Sales & Marketing

Launch Excellence: Moments of Truth

The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting engagement patterns, creating challenges and opportunities.

Sales & Marketing

commercialisation of digital innovation - the new frontier

Why commercialisation is the next frontier for digital innov...

In March, Cigna and its pharmacy benefit manager subsidiary Evernorth announced plans to limit spending increases on GLP-1 drugs at 15% per year.

Sales & Marketing

Neil Newhouse, Kathy Rice, Greg Walden, and Friz Bittenbender at BIO 2024

At BIO 2024, an industry vows to reclaim its narrative

At BIO2024 experts agreed that in a period where pharma is deeply unpopular, the industry must be proactive in telling its story.

Sales & Marketing

12 Questions with Kirsten Parr

Kirsten Parr heads up CMC Connect, a division of IPG Health Medical Communications, and has over 25 years’ experience in the industry.

Sales & Marketing

12 Questions with Michael Stevinson

Michael Stevinson is Global Agency Head at Caudex, an IPG Health Medical Communications company.

The B2C prescription: Marketing lessons for B2B pharma compa...

Launch Excellence: Moments of Truth

Why commercialisation is the next frontier for digital innov...

At BIO 2024, an industry vows to reclaim its narrative

12 Questions with Kirsten Parr

12 Questions with Michael Stevinson

FDA issues warning letters to five unapproved GLP-1 websites

Discover a new era of healthcare panel engagement: Grounded ...

Views & Analysis

Editor's Picks